Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

Learn More

VICC toll-free number 1-877-936-8422

Clinical Trial VICCGI0372

Title

Outcomes Following Image-Guided Therapy for Hepatic Malignancies.

Principal Investigator(s)

Steven Meranze

Details

  • Protocol No. VICCGI0372
  • Open Date: 10/01/2003
  • Staging: Pilot
  • Age Group: Adults
  • Scope: Local
  • Objective:
  • Disease Sites: Gastrointestinal; Liver; Neuroendocrine
  • Therapies: None Specified
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University
  • National Clinical Trial ID: NCT00482586
  • Secondary Protocol No: VICCGI0372

Description

None Provided.

Eligibility

Ages Eligible for Study:18 Years and older
Genders Eligible for Study:Both
Accepts Healthy Volunteers:No

Criteria

DISEASE CHARACTERISTICS:
• Undergoing concurrent image-guided therapy for hepatic malignancies using any of the following imaging techniques:
• X-ray
• Ultrasound
• MRI
• CT scan
• Nuclear medicine imaging
PATIENT CHARACTERISTICS:
• Not specified
PRIOR CONCURRENT THERAPY:
• See Disease Characteristics